These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3763817)

  • 1. Comparative effects of alfacalcidol and parathyroidectomy with vitamin D in hyperparathyroid renal bone disease.
    Cundy T; Kanis JA; Earnshaw M; Woods CG
    Q J Med; 1986 Jul; 60(231):659-70. PubMed ID: 3763817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroidectomy in chronic renal failure: comparison of three operative strategies.
    Nicholson ML; Veitch PS; Feehally J
    J R Coll Surg Edinb; 1996 Dec; 41(6):382-7. PubMed ID: 8997024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid surgery in chronic renal insufficiency. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation to the forearm.
    Malmaeus J; Akerström G; Johansson H; Ljunghall S; Nilsson P; Selking O
    Acta Chir Scand; 1982; 148(3):229-38. PubMed ID: 6753430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroidectomy in the treatment of renal osteodystrophy. Calcium dynamic studies.
    Hubay CA; Gonzalez-Barcena D; Klein L; Frankel V; Eckel RE; Pearson OH
    Arch Surg; 1970 Aug; 101(2):181-92. PubMed ID: 5451199
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.
    Rix M; Eskildsen P; Olgaard K
    Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
    Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure.
    Malmaeus J; Grimelius L; Johansson H; Akerström G; Ljunghall S
    Scand J Urol Nephrol; 1984; 18(2):157-66. PubMed ID: 6379860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised clinical study of alfacalcidol and paricalcitol.
    Hansen D
    Dan Med J; 2012 Feb; 59(2):B4400. PubMed ID: 22293059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total parathyroidectomy and autotransplantation.
    Diaz-Buxo JA; Geissinger WT; Walker PJ; Chandler JT; Farmer CD; Holt KL; Wolfe P
    Clin Nephrol; 1981 Dec; 16(6):276-82. PubMed ID: 7318261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroidectomy in chronic renal failure.
    Sivula A; Kuhlbäck B; Kock B; Kahri A; Wallenius M; Edgren J
    Acta Chir Scand; 1979; 145(1):19-25. PubMed ID: 433513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF; Borra S; Sagar S
    Trans Assoc Am Physicians; 1970; 83():245-53. PubMed ID: 5505392
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy.
    Heath DA; Van't Hoff W; Barnes AD; Gray JG
    Br Med J; 1979 Feb; 1(6161):450-2. PubMed ID: 427402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.